期刊文献+

构建shRNA慢病毒载体抑制U937细胞株VEGFR-1基因的表达 被引量:3

Inhibition of VEGFR-1 gene expression in U937 cell line using Lentivirus-mediated shRNA
下载PDF
导出
摘要 目的构建针对血管内皮生长因子受体1(vascular endothelial growth factor receptor 1,VEGFR-1)基因的siRNA前体表达载体,鉴定其对U937细胞株VEGFR-1基因干扰效率。方法体外设计并合成针对VEGFR-1基因的慢病毒shRNA干扰载体,通过PCR及测序证实载体构建成功。将慢病毒颗粒以最适滴度转染人单核白血病细胞株U937,应用Real-Time PCR、Western印迹法检测抑制效率。结果构建的慢病毒载体的序列通过PCR、测序等鉴定,与设计序列相同。Real-Time PCR检测显示U937细胞干扰组VEGFR-1 mRNA表达率下降75.98%,Western印迹法显示U937细胞干扰组VEGFR-1蛋白表达量较空白载体对照组明显减少。结论构建的shRNA表达载体可在mRNA和蛋白水平上有效抑制U937细胞株VEGFR-1基因的表达。 Objective To construct the shRNA expression vector targeting human vascular en- dothelial growth factor receptor 1 (VEGFR-I) gene and to detect its silencing effects on human monocytic leukemia cell line U937. Methods Three pairs of target segments were synthesized and cloned into pRNAT-U6.2 Lentiviral vector respectively and the vectors were identified by PCR and DNA sequencing. Then the expression vectors were transferred into U937 cell line to produce pack- aged lentivirus. After being infected with the packaged lentivirus, the expression of VEGFR-1 gene of U937 cell line at mRNA and protein level was detected by Real-Time PCR and Western blotting. Results PCR and DNA sequencing showed that the target segments were cloned into pRNAT- U6.2 lentiviral vector respectively. The expression rate of VEGFR-1 gene in U937 cells in the RNA interference group had dropped by 75.98% as compared to that of the control by Real-Time PCR.Western blot also showed decreased expression of the VEGFR-1 protein in the RNA interference group. Conelusion The shRNA expression vector effectively inhibits the expression of VEGFR-1 gene in U937 cell line on mRNA and protein levels.
出处 《同济大学学报(医学版)》 CAS 2010年第1期12-16,共5页 Journal of Tongji University(Medical Science)
基金 国家自然科学基金资助资助项目(30572161)
关键词 血管内皮生长因子受体1 RNA干扰 慢病毒 U937细胞系 vascular endothelial growth factor receptor 1 RNA interference lentivirus U937 cell line
  • 相关文献

参考文献10

二级参考文献36

  • 1梁爱斌,李莉,谢晓恬,江华,叶辉,赵金彩,顾龙君.急性淋巴细胞白血病患儿血管内皮生长因子及其受体的表达与临床相关性的初步研究[J].中华血液学杂志,2005,26(8):489-492. 被引量:10
  • 2Krauth MT, Simonitsch I, Aiehberger K J, et al. Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease. Am J Clin Pathol, 2004, 121 : 473-481.
  • 3Bellamy WT, Richler L, Sirjani D, et al. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. Blood, 2001, 97: 1427-1434.
  • 4Dias S, Hattori K, Zhu Z, et al . Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest, 2000, 106:511-521.
  • 5Dias S, Shmelkov SV, Lam G, et al. VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition. Blood, 2002, 99: 2532-2540.
  • 6Le Gouill S, Podar K, Amiot M, et al. VEGF induces MCL-1 up-regulation and protects muhiple myeloma cells against apoptosis. Blood, 2004,104:2886-2892.
  • 7Katoh O, Takahashi T, Oguri T, et al. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor. Cancer Res, 1998, 58: 5565-5569.
  • 8Avramis IA, Kwock R, Avramis VI. Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines. Anticancer Res, 2001, 21:2281-2286.
  • 9Doggrell SA. Vascular biology support for the use of bevacizumab in colorectal cancer. Expert Opin Investig Drugs, 2004, 13: 703-705.
  • 10Vokes E, Herbst R, Sandier A. Angiogenesis inhibition in the treatment of lung cancer. Clin Adv Hematol Oncol, 2006, 4: 1-10; quiz 11-12.

共引文献14

同被引文献42

  • 1杨奕清,刘懿,夏敏,董雄剑,林捷,陈义汉.hKCNE5基因克隆及其重组腺病毒表达载体的构建[J].同济大学学报(医学版),2006,27(5):1-5. 被引量:1
  • 2王建军,刘彧,王宏卫,廖小玲,朱诗应,李怀芳.siRNA抑制survivin的表达诱导人卵巢癌SKOV-3细胞凋亡的研究[J].同济大学学报(医学版),2007,28(2):14-18. 被引量:4
  • 3刘娜,严海东,李雪竹.MCP-1siRNA真核表达载体的构建及其对HKC MCP-1基因沉默效应的鉴定[J].同济大学学报(医学版),2007,28(2):42-46. 被引量:1
  • 4Shilling RA,Wilkes DS.Immunobiology of chronic lung allograft dysfunction:new insights from the bench and beyond[J].Am J Transplant,2009,9(8):1714-1718.
  • 5Christie JD,Edwards LB,Aurora P,et al.Registry of the international society for heart and lung transplantation:twenty-fifth official adult lung and heart/lung transplantation report-2008[J].Heart Lung Transplant,2008,27(9); 957-969.
  • 6Marshak RA,Rifkin IR.Immunologically active auto antigens:the role of toll-like receptors in the development of chronic inflammtory disease[J].Annu Rev Immunol,2007,25:419-441.
  • 7Garantziotis S,Palmer SM,Snyder LD,et al.Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide[J].Transplantation,2007,84(8):1012-1019.
  • 8Moffat J,Sabatini DM.Building mammalian signalling pathways with RNAi screens[J].Nat RevMol Cell Biol,2006,7 (3):177-187.
  • 9Tanaka T,Legat A.DiC14-amidine cationic iiposomes stimulate myeloid dendritic cells through Toil-like receptor 4[J].Eur J Immnnol,2008,38(5):1351-1357.
  • 10Tong P,Wu C,Jin H. Gene expression profile of steroid-induced necrosis of femoral head of rats[J].Calcified Tissue International,2011,(04):271-284.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部